Viekira Pak Effective Without Ribavirin
AbbVie hepatitis C cocktail succeeds in late-stage study
June 24, 2015
AbbVie Inc said on Wednesday that its hepatitis C cocktail Viekira Pak was effective whether or not it was used in combination with the compound ribavirin against the most common form of the disease, according to data from a late-stage study.
Viekira Pak, a combination of the drugs Viekirax and Exviera, was approved in December for use as both a standalone treatment and in tandem with ribavirin, a broad-spectrum antiviral approved in 1998.
Continue reading this entire article:
Tired with Hep C? Avoid These 5 Foods!
Marijuana After Clearing Hepatitis C